(Q28583180)

31 January 2017

title

Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression (English)

1 reference

31 January 2017

1 reference

L. Burchill

1

1 reference

31 January 2017

E. Velkoska

2

1 reference

31 January 2017

R. G. Dean

3

1 reference

31 January 2017

R. A. Lew

4

1 reference

31 January 2017

A. I. Smith

5

1 reference

31 January 2017

V. Levidiotis

6

1 reference

31 January 2017

L. M. Burrell

7

1 reference

31 January 2017

publication date

1 May 2008

1 reference

31 January 2017

published in

Experimental Physiology

1 reference

31 January 2017

volume

93

1 reference

31 January 2017

issue

5

1 reference

31 January 2017

page(s)

622–630

1 reference

ACE2, a new regulator of the renin-angiotensin system

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040386

Myocardial infarction increases ACE2 expression in rat and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040386

A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040386

Vasopeptidase inhibition attenuates the progression of renal injury in subtotal nephrectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040386

Angiotensin-converting enzyme 2 is an essential regulator of heart function

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040386

Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040386

Connective tissue growth factor and cardiac fibrosis after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040386

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040386

Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040386

Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040386

Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040386

Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040386

Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040386

Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040386

Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040386

Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040386

Chronic kidney disease and mortality risk: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040386

Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040386

Inhibition of Rabbit Brain Prolyl Endopeptidase by N‐Benzyloxycarbonyl‐Prolyl‐Prolinal, a Transition State Aldehyde Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040386

Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040386

Immunolocalization of ACE2 and AT2 receptors in rabbit atherosclerotic plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040386

Renal function and risk for cardiovascular events in type 2 diabetic patients with hypertension: the RENAAL and LIFE studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040386

Cardiac remodelling in experimental renal failure - an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040386